India · Delayed Price · Currency is INR Indrayani Biotech Statistics
Total Valuation
BOM:526445 has a market cap or net worth of INR 468.11 million. The enterprise value is 1.80 billion.
| Market Cap | 468.11M |
| Enterprise Value | 1.80B |
Important Dates
The last earnings date was Monday, August 17, 2026.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:526445 has 45.54 million shares outstanding. The number of shares has increased by 294.47% in one year.
| Current Share Class | 45.54M |
| Shares Outstanding | 45.54M |
| Shares Change (YoY) | +294.47% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 58.72% |
| Owned by Institutions (%) | 3.66% |
| Float | 18.66M |
Valuation Ratios
The trailing PE ratio is 126.27.
| PE Ratio | 126.27 |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| PB Ratio | 0.46 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | 2.84 |
| P/OCF Ratio | 1.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.66, with an EV/FCF ratio of 10.92.
| EV / Earnings | 485.45 |
| EV / Sales | 1.30 |
| EV / EBITDA | 12.66 |
| EV / EBIT | 18.16 |
| EV / FCF | 10.92 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.71 |
| Quick Ratio | 0.68 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 9.03 |
| Debt / FCF | 7.79 |
| Interest Coverage | 1.03 |
Financial Efficiency
Return on equity (ROE) is 2.14% and return on invested capital (ROIC) is 4.22%.
| Return on Equity (ROE) | 2.14% |
| Return on Assets (ROA) | 2.37% |
| Return on Invested Capital (ROIC) | 4.22% |
| Return on Capital Employed (ROCE) | 6.17% |
| Weighted Average Cost of Capital (WACC) | 5.47% |
| Revenue Per Employee | 1.47M |
| Profits Per Employee | 3,956 |
| Employee Count | 936 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | -18.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.74% in the last 52 weeks. The beta is 0.00, so BOM:526445's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | -15.74% |
| 50-Day Moving Average | 7.98 |
| 200-Day Moving Average | 9.87 |
| Relative Strength Index (RSI) | 70.52 |
| Average Volume (20 Days) | 77,606 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:526445 had revenue of INR 1.38 billion and earned 3.70 million in profits. Earnings per share was 0.08.
| Revenue | 1.38B |
| Gross Profit | 437.58M |
| Operating Income | 99.01M |
| Pretax Income | 3.00M |
| Net Income | 3.70M |
| EBITDA | 142.02M |
| EBIT | 99.01M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 42.56 million in cash and 1.28 billion in debt, with a net cash position of -1.24 billion or -27.24 per share.
| Cash & Cash Equivalents | 42.56M |
| Total Debt | 1.28B |
| Net Cash | -1.24B |
| Net Cash Per Share | -27.24 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 16.03 |
| Working Capital | 657.39M |
Cash Flow
In the last 12 months, operating cash flow was 316.54 million and capital expenditures -151.92 million, giving a free cash flow of 164.62 million.
| Operating Cash Flow | 316.54M |
| Capital Expenditures | -151.92M |
| Depreciation & Amortization | 43.01M |
| Net Borrowing | -71.50M |
| Free Cash Flow | 164.62M |
| FCF Per Share | 3.62 |
Margins
Gross margin is 31.75%, with operating and profit margins of 7.18% and 0.27%.
| Gross Margin | 31.75% |
| Operating Margin | 7.18% |
| Pretax Margin | 0.22% |
| Profit Margin | 0.27% |
| EBITDA Margin | 10.30% |
| EBIT Margin | 7.18% |
| FCF Margin | 11.94% |
Dividends & Yields
BOM:526445 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -294.47% |
| Shareholder Yield | -294.47% |
| Earnings Yield | 0.79% |
| FCF Yield | 35.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |